Abstract:Background: Prompt reperfusion is essential to rescue ischemic tissue, but in itself represents a key pathomechanism contributing to poor outcome after cardiac arrest. Experimental data suggest levosimendan as a therapeutic drug to limit ischemia-reperfusion injury by improving cerebral microcirculation and thereby reducing neuronal injury. However, recent studies question its effect on cardiac output and cerebral microcirculation in normally pumping hearts. The present study was designed to investigate the in… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.